相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time
Lars H. Lund et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2017)
Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab
David Ansari et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents
Bryan A. Whitson et al.
CLINICAL TRANSPLANTATION (2015)
A randomized controlled trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation
John C. Mullen et al.
TRANSPLANTATION RESEARCH (2014)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Induction Immunosuppression Improves Long-Term Graft and Patient Outcome in Organ Transplantation: An Analysis of United Network for Organ Sharing Registry Data
Junchao Cai et al.
TRANSPLANTATION (2010)
Induction Immunosuppression With Basiliximab in Heart Transplantation
N. K. Chou et al.
TRANSPLANTATION PROCEEDINGS (2008)
Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thyrnocyte globulin as induction therapy
Marie Francoise Mattei et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2007)
Basiliximab and rabbit anti-thyrnocyte globulin for prophylaxis of acute rejection after heart transplantation: A non-inferiority trial
Michel Carrier et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2007)
Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation
Flavia Flaman et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2006)
Ten-year follow-up of a prospective, randomized trial of BT563/BB10 versus anti-thymocyte globulin as induction therapy, after heart transplantation
Nikolaos Bonaros et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2006)
Daclizumab to prevent rejection after cardiac transplantation
RE Hershberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
To induce or not to induce: Do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?
R Higgins et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation
MR Mehra et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Neoplastic disease after heart transplantation:: single center experience
M Rinaldi et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2001)
Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody.
A Beniaminovitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
